Petros Pharmaceuticals, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Petros Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Petros Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -57.2 %, a 41.4% increase year-over-year.
  • Petros Pharmaceuticals, Inc. annual Return On Equity for 2023 was -68.9 %, a 7.73% increase from 2022.
  • Petros Pharmaceuticals, Inc. annual Return On Equity for 2022 was -74.7 %, a 94.9% decline from 2021.
  • Petros Pharmaceuticals, Inc. annual Return On Equity for 2021 was -38.3 %, a 96.1% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -68.9 +5.77 +7.73% Jan 1, 2023 Dec 31, 2023
2022 -74.7 -36.4 -94.9% Jan 1, 2022 Dec 31, 2022
2021 -38.3 +936 +96.1% Jan 1, 2021 Dec 31, 2021
2020 -975 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.